When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CYDY - CytoDyn completes enrollment in leronlimab study for COVID-19; results expected by mid-October
CytoDyn Inc
CytoDyn (OTCQB:CYDY) has reached the requisite number of enrolled patients in its Phase 3 trial of leronlimab in COVID-19 patients with severe-to-critical symptoms to perform an interim analysis following the 28-day phase of the trial, with results anticipated by mid-October.
More news on: CytoDyn Inc., Healthcare stocks news,